Hearing the words “heart failure” can feel like someone pulled the rug out from under you. Shortness of breath, trips to the emergency department, and the ever-present fear of “Will my heart keep up?” can make every day feel uncertain. The sheer number of pills, diet rules, and doctor visits only adds to the overwhelm. But there is genuinely encouraging news: pairing two specific types of drugs is rewriting the outlook for millions of Americans living with heart failure. Studies show the duo can cut the odds of dying or landing back in the hospital by nearly half compared with older drug combinations, transforming “maintenance therapy” into proactive protection. Read on to learn about this medication duo and how it can fit into your heart failure treatment regimen.
Heart Failure in America: Scope and Burden
According to the Heart Failure Society of America, heart failure affects about 6.7 million adults in the United States today—a number projected to soar to 8.7 million by 2030 as the population ages. That means that one in four people will develop heart failure in their lifetime.
Heart failure happens when the heart muscle can’t pump enough blood to meet the body’s needs. The body might not even get enough oxygen. You may then experience fatigue and shortness of breath, as well as excessive coughing. Heart failure leads to fluid buildup in the lungs and legs, relentless fatigue, lack of appetite, confusion, and more. You might experience a frustrating cycle of improvement and relapse. Despite modern medicine, five-year survival still rivals that of many cancers, making aggressive early treatment essential.
How Heart Failure Happens—and Why It Feels Overwhelming
The syndrome develops after years of strain from issues like high blood pressure, coronary artery disease, diabetes, or a prior heart attack. Genetics, viral infections, obesity, and valvular problems, among other things, can also weaken the heart and increase the risk of heart disease. Whatever the trigger, the body responds with a flood of hormones that, unfortunately, make the situation worse, causing salt retention, stiffening of the heart walls, and further weakening of the pump.
If you live with heart failure, you already know the emotional toll: wondering whether climbing stairs will leave you gasping, counting milligrams of sodium at every meal, and worrying every time your scale shows an extra pound overnight. Others rarely understand how hard it is to live with a condition like heart failure that affects your everyday, every-minute, life. That anxiety is real, but effective therapy works to ease it.
Every Tool in the Toolbox: A Walk-Through of Modern Therapies
The 2022 American Heart Association (AHA), American College of Cardiology (ACC), and Heart Failure Society of America (HFSA) Guideline for the Management of Heart Failure has laid out evidence-based ways to treat heart failure. The good news is that there are many evidence-based treatments available.
The guideline breaks care into four life-stages—from “at-risk” people with high blood pressure or diabetes, to those with advanced disease who may need a heart pump or transplant. Here’s what treatment guidelines look like without the medical jargon.
1. Stop Trouble Before It Starts—If you have high blood pressure, clogged arteries, diabetes, obesity, or you smoke, you’re on the runway to heart failure. The guideline’s first message is simple: control those risks early.
• Keep blood pressure and cholesterol in check.
• Quit smoking, move your body, and watch your salt intake and weight.
• If you have type 2 diabetes, newer drugs called SGLT2 inhibitors (like empagliflozin [Jardiance] or dapagliflozin [Farxiga]) protect both heart and kidneys and even cut your odds of getting heart failure later on.
2. The “Fantastic Four” Medicines for a Weak Pump—When tests show the heart’s squeeze (called the ejection fraction) is 40% or less, the guidelines urge doctors to start four cornerstone medicines within a few weeks, not months:
• Sacubitril/valsartan (Entresto)—relaxes blood vessels and helps the heart heal.
• A beta-blocker like metoprolol (Toprol) or carvedilol (Coreg)—slows the heart so it works more efficiently.
• Spironolactone (Aldactone) or eplerenone (Inspra)—prevent your body from absorbing too much salt and keep your potassium levels from getting too low; this prevents scarring inside the heart.
• An SGLT2 inhibitor—the diabetes drugs mentioned above, now proven to keep heart-failure patients out of the hospital.
Taken together, these four cut deaths and emergency room visits by roughly half compared with older treatment plans.
3. When the Pump Number Looks “Normal”—Some people have heart-failure symptoms even though their ejection fraction is above 40%. For them, weight control, blood-pressure management, and SGLT2 inhibitors are the frontline therapies; other drugs also help on a case-by-case basis.
4. Gadgets and High-Tech Help—Some people also benefit from one of the following options:
• An implantable cardioverter-defibrillator (ICD): a surgically implanted device that prevents sudden death for many with a weak heart by guarding against dangerously fast or chaotic rhythms
• Cardiac-resynchronization therapy (CRT): delivered by a special implanted device that coordinates the two halves of the heartbeat when the heart’s wiring is slow (known as an electrical conduction delay)
• A remote pressure sensor: a tiny device placed in a lung artery that warns your team you’re building fluid, often before you feel it
If medicines and gadgets still don’t control symptoms, a left-ventricular assist device (LVAD)—a mechanical pump—or a heart transplant may be your best option.
When looking at heart failure treatment, the best outcomes come from acting fast: tackle risk factors early, start the four key medicines quickly after diagnosis, add devices or advanced therapies when needed, and weave in lifestyle changes and support every step of the way.
The Power Couple: Sacubitril/Valsartan (Entresto) and Empagliflozin (Jardiance)
There is also a powerful cardiac drug duo that’s important to know about. Sacubitril/valsartan (Entresto) and empagliflozin (Jardiance) work in separate physiological ways, providing additive benefits.
When doctors prescribe both drugs early, patients spend fewer anxious nights in the hospital and more stable months at home, often with better kidney function and less swelling. For many, that translates into walking the dog without gasping or attending a granddaughter’s soccer game instead of watching from the car.
The technical bits: Sacubitril/valsartan (Entresto) boosts helpful natriuretic peptides while suppressing the renin–angiotensin system, easing pressure inside the heart, and preventing scarring. Empagliflozin (Jardiance), a SGLT2 inhibitor, meanwhile, prompts the kidneys to excrete extra sodium and glucose, lightening the heart’s workload and improving energy metabolism. Because they work in separate pathways, the benefits add up rather than overlap.
Studies supporting this combination include:
• PARADIGM-HF showed sacubitril/valsartan reduced cardiovascular death or first heart failure hospitalization by 20% compared to the angiotensin-converting enzyme (ACE) inhibitor enalapril (Vasotec).
• EMPEROR-Reduced and EMPEROR-Preserved demonstrated that empagliflozin lowered the cardiovascular death or first heart failure hospitalization by 25–30%, whether the heart’s ejection fraction was low or nearly normal.
Tackling Practical Concerns: Cost and Access
Many commercial plans and Medicare Part D now list sacubitril/valsartan and SGLT2 inhibitors as preferred drugs, but copays can still sting. This has made them hard to access in the past, however, The Inflation Reduction Act caps out-of-pocket spending for Medicare beneficiaries starting in 2025, potentially saving hundreds per year on these medications. Additionally, both Novartis and Boehringer Ingelheim/Eli Lilly also offer copay cards or patient-assistance programs. Ask your pharmacist or visit the company websites for more information one how these can possibly save you money.
Living With Heart Failure: Tips to Regain Control
Medication is powerful, but lifestyle changes remain the secret sauce. Try to maintain these changes:
• Track weight every morning. A sudden two-pound jump can signal fluid retention.
• Limit sodium. Shoot for under 2,000 milligrams per day (read those labels carefully).
• Move in small amounts throughout the day. Five-minute walks sprinkled through the day always beat zero exercise.
• Get your vaccinations. Flu, COVID-19, and pneumonia shots can keep you out of the hospital, and thus, project your heart.
• Seek support. Heart-failure groups—online or in-person—offer tips and a place to vent with ones who really understand what you’re going through.
• See your doctor regularly. Regular check-ups can catch problems early.
Remember, feeling scared is normal, but knowledge replaces fear with action. The more you understand your medications and routine, the more confident you’ll feel.
The Final Word on Heart Failure Treatment
Heart failure is tough—physically, emotionally, and sometimes financially—but it isn’t a one-way street. Every small decision you and your healthcare team make (from trimming salt at dinner to adding the right medication at the right time) can lighten the load on your heart and widen the path back to a fuller life. Today’s evidence tells us that combining sacubitril/valsartan and empagliflozin can be a game-changer, yet those medicines work best when they sit on a solid foundation of healthy habits, regular follow-ups, and honest conversations with your doctor and loved ones about what matters most to you.
So, keep asking questions, track your symptoms, celebrate each good walk or good day, and lean on the people eager to help—family, friends, pharmacists, nurses, and fellow patients who “get it.” Heart failure may be part of your story, but with the right tools and support, it doesn’t have to write the ending.
Sources
1. Bozkurt, B. et al. (2025, January). HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America. Journal of Cardiac Failure, 31(1), 66 – 116. https://onlinejcf.com/article/S1071-9164(24)00232-X/abstract
2. Cotter, G., Davison, B. A., Lam, C. S. P., Metra, M., Ponikowski, P., Teerlink, J. R., & Mebazaa, A. (2023). Acute heart failure is a malignant process: but we can induce remission. Journal of the American Heart Association, 12(21). https://doi.org/10.1161/jaha.123.031745
3. Heart failure - Symptoms and causes. (2025, January 21). Mayo Clinic. Retrieved May 20, 2025, from https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142
4. Heart Failure Signs and Symptoms. (2023, June 13). American Heart Association. Retrieved May 20, 2025, from https://www.heart.org/en/health-topics/heart-failure/warning-signs-of-heart-failure
5. Heidenreich, P. A., Bozkurt, B. et al. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145(18). https://doi.org/10.1161/cir.0000000000001063
6. Kumbhani, D. J. (2020, August 28). Empagliflozin Outcome Trial in patients with chronic heart failure and a reduced ejection fraction - American College of Cardiology. American College of Cardiology. Retrieved May 20, 2025, from https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2020/08/28/16/12/EMPEROR-Reduced
7. McKeown, L. (2023, January 13). HFREF’s financial burden may get relief from Inflation Reduction Act. TCTMD.com. https://www.tctmd.com/news/hfrefs-financial-burden-may-get-relief-inflation-reduction-act
8. Packer, M., McMurray, J. J. et al. (2014). Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation, 131(1), 54–61. https://doi.org/10.1161/circulationaha.114.013748
9. Shams, P., Chhabra, L., & Malik, A. (2025, February 26). Heart failure (Congestive heart failure). Treatment & Management | Point of Care. https://www.statpearls.com/point-of-care/22661
10. What is Heart Failure? (2025, May 20). American Heart Association. https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure
###